医学
间歇性缺氧
缺氧(环境)
内科学
心脏病学
纤维化
睡眠呼吸暂停
心室重构
阻塞性睡眠呼吸暂停
呼吸暂停
内分泌学
心力衰竭
有机化学
化学
氧气
作者
Anabel L. Castro-Grattoni,Roger Alvarez-Buvé,Marta Torres,Ramón Farré,Josep M. Montserrat,Mireia Dalmases,Isaac Almendros,Ferrán Barbé,Manuel Sánchez‐de‐la‐Torre
出处
期刊:Chest
[Elsevier]
日期:2016-06-01
卷期号:149 (6): 1400-1408
被引量:62
标识
DOI:10.1016/j.chest.2015.11.010
摘要
Intermittent hypoxia (IH) is the principal injurious factor involved in the cardiovascular morbidity and mortality associated with OSA. The gold standard for treatment is CPAP, which eliminates IH and appears to reduce cardiovascular risk. There is no experimental evidence on the reversibility of cardiovascular remodeling after IH withdrawal. The objective of the present study is to assess the reversibility of early cardiovascular structural remodeling induced by IH after resumption of normoxic breathing in a novel recovery animal model mimicking OSA treatment.We investigated cardiovascular remodeling in C57BL/6 mice exposed to IH for 6 weeks vs the normoxia group and its spontaneous recovery after 6 subsequent weeks under normoxia.Aortic expansive remodeling was induced by IH, with intima-media thickening and without lumen perimeter changes. Elastic fiber network disorganization, fragmentation, and estrangement between the end points of disrupted fibers were increased by IH. Extracellular matrix turnover was altered, as visualized by collagen and mucoid interlaminar accumulation. Furthermore, left ventricular perivascular fibrosis was increased by IH, whereas cardiomyocytes size was unaffected. These cardiovascular remodeling events induced by IH were normalized after recovery in normoxia, mimicking CPAP treatment.The early structural cardiovascular remodeling induced by IH was normalized after IH removal, revealing a novel recovery model for studying the effects of OSA treatment. Our findings suggest the clinical relevance of early detection and effective treatment of OSA in patients to prevent the natural course of cardiovascular diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI